Freehold, NJ, United States of America

Gaye Margiatto

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaye Margiatto. Retrieved from https://idiyas.com/inventor/gaye-margiatto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaye Margiatto: Innovator in Antiparasitic Agents

Introduction

Gaye Margiatto is a notable inventor based in Freehold, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiparasitic agents. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to improving health outcomes.

Latest Patents

Gaye Margiatto holds a patent for "Avermectin derivatives with a spacer inserted between the disaccharide." This patent discloses avermectin derivatives that incorporate a spacer between the disaccharide and the aglycone. The synthetic spacer-containing analogs are derived from corresponding aglycones, which are prepared through chemical modification of naturally occurring avermectins. The compounds developed are recognized as active antiparasitic agents, and compositions for their use are also disclosed.

Career Highlights

Gaye Margiatto is currently employed at Merck & Company, Inc., where she continues to advance her research and development efforts. Her work at Merck has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical innovations.

Collaborations

One of her notable coworkers is Timothy A. Blizzard. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective projects.

Conclusion

Gaye Margiatto's work in developing avermectin derivatives exemplifies her commitment to creating effective antiparasitic agents. Her contributions to the pharmaceutical industry are significant and continue to impact health positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…